Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, 405 Life Sciences Addition, Berkeley, CA 94720-3200, USA.
Curr Opin Immunol. 2011 Feb;23(1):3-9. doi: 10.1016/j.coi.2010.11.006. Epub 2010 Dec 14.
Trafficking and activation of the nucleic acid sensing TLRs is subject to unique regulatory requirements imposed by the risk of self-recognition. Like all TLRs these receptors traffick through the Golgi, however, access to the secretory pathway is controlled by a binding partner present in the ER. Receptor activation in the endolysosome is regulated through a proteolytic mechanism that requires activity of compartment-resident proteases, thereby preventing activation in other regions of the cell. Advances in our understanding of the cell biology of these receptors have been paralleled by efforts to understand their precise roles in autoimmunity. Mouse models have revealed that TLR7 and TLR9 make unique contributions to the types of self-molecules recognized in disease and possibly disease severity. Currently, methods of inhibiting TLR7 and TLR9 are being tested in clinical trials for systemic lupus erythamatosus.
核酸感应 TLR 的贩运和激活受到自我识别风险带来的独特调控要求的限制。与所有 TLR 一样,这些受体通过高尔基体运输,但是,对分泌途径的访问受到内质网中存在的结合伴侣的控制。内体溶酶体中的受体激活受蛋白水解机制调控,该机制需要驻留在隔室中的蛋白酶的活性,从而防止在细胞的其他区域激活。我们对这些受体的细胞生物学的理解的进展伴随着对其在自身免疫中的确切作用的理解。小鼠模型表明,TLR7 和 TLR9 对疾病中识别的自身分子的类型及其可能的疾病严重程度做出了独特的贡献。目前,抑制 TLR7 和 TLR9 的方法正在系统性红斑狼疮的临床试验中进行测试。